Welcome

"Melville Library, SUNY Stony Brook"

Log
In (Register)
| Log
Out

Errata
Annual
Review of Pharmacology and Toxicology

NEUROKININ1 RECEPTOR ANTAGONISTS AS
POTENTIAL ANTIDEPRESSANTS

Steven C. Stout, Michael J. Owens,
and Charles B.
Nemeroff

Sections:

ChooseAddendum

Addendum

Section:

ChooseTop of
pageAddendum
<<

(provided to Annual Reviews on 10 May 2004)

Disclosure Statement

At the time of manuscript submission (August 2000), C.B.N.
consulted with the following pharmaceutical advisory boards: Abbott
Laboratories, Astra-Zeneca, Forest Laboratories, GlaxoSmithKline,
Janssen, Merck, Nerocrine Biosciences, Organon Pharmaceuticals,
Somerset Pharmaceuticals, and Wyeth-Ayerst Laboratories. Also at the
time of manuscript submission, M.J.O. consulted with Cielo
Institute. M.J.O. received research grants from SmithKline-Beecham,
NARSAD, Cielo Institute, and the NIH; as well as honoraria from
SmithKline-Beecham and Pharmacia.

Series
Home > Article
Addenda > Errata

Prev.
Article | Next Article
Add
to Favorites
Email
link to a friend

Quick Links

•

Original
Article

•

Alert me
when:
New
articles cite this article

•

Download
to citation manager

•

Related
articles found in:
Annual
Reviews

•

View
Most Downloaded
Reviews

Quick Search

Annual
Reviews

for

Authors:

Steven C. Stout,

Michael J. Owens, and

Charles B.
Nemeroff

©
2006 Annual Reviews. All Rights Reserved.

Technology Partner - Atypon Systems,
Inc.